These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1418927)

  • 21. Atherosclerosis: cell biology and lipoproteins.
    Lu H; Daugherty A
    Curr Opin Lipidol; 2009 Dec; 20(6):528-9. PubMed ID: 19935204
    [No Abstract]   [Full Text] [Related]  

  • 22. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.
    Ebara T; Ramakrishnan R; Steiner G; Shachter NS
    J Clin Invest; 1997 Jun; 99(11):2672-81. PubMed ID: 9169497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mouse model with features of familial combined hyperlipidemia.
    Masucci-Magoulas L; Goldberg IJ; Bisgaier CL; Serajuddin H; Francone OL; Breslow JL; Tall AR
    Science; 1997 Jan; 275(5298):391-4. PubMed ID: 8994037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of expression of genes involved in apolipoprotein E-based lipoprotein metabolism in pregnant mice deficient in the receptor-associated protein, the low density lipoprotein receptor, or apolipoprotein E.
    Umans L; Overbergh L; Serneels L; Tesseur I; Van Leuven F
    Biol Reprod; 1999 Nov; 61(5):1216-25. PubMed ID: 10529267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD.
    Baroni MG; Berni A; Romeo S; Arca M; Tesorio T; Sorropago G; Di Mario U; Galton DJ
    BMC Med Genet; 2003 Sep; 4():8. PubMed ID: 12964943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein function in health and disease: insights from natural mutations.
    Franceschini G
    Eur J Clin Invest; 1996 Sep; 26(9):733-46. PubMed ID: 8889435
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B.
    Shimano H; Yamada N; Katsuki M; Yamamoto K; Gotoda T; Harada K; Shimada M; Yazaki Y
    J Clin Invest; 1992 Nov; 90(5):2084-91. PubMed ID: 1430232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct hepatic receptors for low density lipoprotein and apolipoprotein E in humans.
    Hoeg JM; Demosky SJ; Gregg RE; Schaefer EJ; Brewer HB
    Science; 1985 Feb; 227(4688):759-61. PubMed ID: 2982214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the very low density lipoprotein receptor in the metabolism of plasma lipoproteins containing ApoE.
    Yamamoto T; Hoshino A; Takahashi S; Kawarabayasi Y; Iijima H; Sakai J
    Ann N Y Acad Sci; 1995 Jan; 748():217-24; discussion 224-5. PubMed ID: 7695167
    [No Abstract]   [Full Text] [Related]  

  • 30. Mouse models as tools for dissecting disorders of lipoprotein metabolism.
    Marschang P; Herz J
    Semin Cell Dev Biol; 2003 Feb; 14(1):25-35. PubMed ID: 12524004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cafestol increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis.
    Post SM; de Roos B; Vermeulen M; Afman L; Jong MC; Dahlmans VE; Havekes LM; Stellaard F; Katan MB; Princen HM
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1551-6. PubMed ID: 10845871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.
    Aalto-Setälä K; Fisher EA; Chen X; Chajek-Shaul T; Hayek T; Zechner R; Walsh A; Ramakrishnan R; Ginsberg HN; Breslow JL
    J Clin Invest; 1992 Nov; 90(5):1889-900. PubMed ID: 1430212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition.
    Bard JM; Parra HJ; Douste-Blazy P; Fruchart JC
    Metabolism; 1990 Mar; 39(3):269-73. PubMed ID: 2106607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoprotein analysis in transgenic mice expressing human apolipoprotein (apo) A-I and apo C III: use of micromethods in analysis of lipoprotein system in mice.
    Ito Y
    Hokkaido Igaku Zasshi; 1994 Mar; 69(2):312-26. PubMed ID: 8157256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis.
    Vergnes L; Baroukh N; Ostos MA; Castro G; Duverger N; Nanjee MN; Najib J; Fruchart JC; Miller NE; Zakin MM; Ochoa A
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2267-74. PubMed ID: 11031214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory mutations in human lipoprotein disorders and atherosclerosis.
    Kontula K; Ehnholm C
    Curr Opin Lipidol; 1996 Apr; 7(2):64-8. PubMed ID: 8743897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo regulation of low-density lipoprotein receptors by estrogen differs at the post-transcriptional level in rat and mouse.
    Srivastava RA; Baumann D; Schonfeld G
    Eur J Biochem; 1993 Sep; 216(2):527-38. PubMed ID: 8375391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular basis of exchangeable apolipoprotein function.
    Narayanaswami V; Ryan RO
    Biochim Biophys Acta; 2000 Jan; 1483(1):15-36. PubMed ID: 10601693
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study on the differential expression of lipid metabolism-related genes in young LDLR knockout mice liver].
    Shang YJ; Dai XD; Jing W; Du HQ; Ye HY; Yin M; Zhang L; Zhang SQ; Li JF; Pan J
    Zhonghua Bing Li Xue Za Zhi; 2008 Mar; 37(3):179-83. PubMed ID: 18788595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor.
    van Dijk KW; van Vlijmen BJ; van der Zee A; van't Hof B; van der Boom H; Kobayashi K; Chan L; Havekes LM; Hofker MH
    Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):7-12. PubMed ID: 9445249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.